🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📌Visual abstract (VA), seems to be a rising star🌟 in this new #meded & #FOAM era Many journals are adopting VA Cool clubs like #NSMC, #NephJC uses VA How about we discuss creating a VA, shall we!? #Nephtwitter #medtwitter #podkopiluwak #tweetorial

Please leave your suggestions and comments If you would like to contribute to the future #IPNAJC, please DM @ipnajc Signup for our newsletter theipna.org/journalclub/ Sincerely: Michal Malina⚕️ Sudha Mannemuddhu, MD, FAAP, FASN, FNKF Swasti Chaturvedi @kidnyhealth M Abdul Qader🇧🇩 @maurypinsk Shweta Shah M.D; FASN #IPNAJC

#UrinarySediment What does 'active' urine sediment mean? Is there a 'passive' sediment too?

🔥Had a small presentation (12 min ) on Rituximab in ANCA vasculitis . Few things I learnt while making it

Advances in the knowledge of antigens involved in the development of membranous nephropathy have improved our understanding of this condition. This article describes personalized treatment of PLA2R-related membranous nephropathy bit.ly/CJASN086 @pi_ronco

There are 5 classes of diuretics we can consider. You don’t have to just use furosemide! Everyone’s favourite loop… Let’s use our physiology and pharmacology knowledge to combine some of them, to achieve good natriuresis as well as diuresis👍👏🤷‍♂️

Happy July! Episode just released on IgAN- adult vs. pediatric perspectives with GN experts Sean Barbour and Alexandra Cambier New nephrology fellows- welcome 👏and use this podcast as a go-to resource😀 open.spotify.com/episode/5JTg2O… American Society of Nephrology KDIGO Renal Fellow Network American Society of Pediatric Nephrology

#IPNAJC What drugs are used in your institute to treat SDNS in children?

What Rituximab dose do you use in SDNS?

Hepatitis A to E in 60 seconds 🧠💡(fixed sound) #MedEd

Teaching subepithelial deposits (humps). 1) Infection-related GN (top panel) 2) C3 glomerulopathy 3) Proliferative GN due monoclonal Ig (bottom panel) 4) Lupus (Autoimmune) GN Humps likely reflect complement. Subepithelial location prevents removal & humps persist a long time.

X0A Systemic lupus erythematosus (SLE) is a rare, severe and life-long disease involving many organ systems. About 15 to 20% have childhood onset of SLE. #IPNAJC

I wonder if in resource-limited settings where tertiary setups are faraway, is also using cyclophosphamide beneficial due to the fear of non-compliance? What drug do you use in Bangladesh? What do you say @md_abdulqader #IPNAJC

Learning from Jean Hou, MD is an absolute dream! She is amazing🌟😍 #Inspired #Nephtwitter #medtwitter What do you see here? Birth of a crescent ;) ? GlomCon fellowship program

We are privileged to have the famous Vanesa Bijol as our pathology director GlomCon Learning so much from her this morning GlomCon fellowship program 🙌🙏 #nephtwitter #MedTwitter

🌟In med school and in practice as well, we are overwhelmed by the number of patients with hypertension and the various anti-hypertensive drugs! 🏅Before diving into tonight’s #NephJC, take a look at the article itself thelancet.com/journals/lance…

#NephJC Hello everyone, Madiha from Karachi, Pakistan here

Antibody-mediated rejection in kidney transplant or a puzzle nephrologists trying to find the missing pieces Could CD38 and felzartamab be the 🗝️? Too early to say! (get it? ph2📷) Read #NephJC comprehensive summary by Kajaree Giri and Mdh Aziz nephjc.com/news/felzartam…

T1c 🔬The molecular score for AMR using the Molecular Microscope Diagnostic System (MMDx) was used here. The MMDx project measures gene transcription on a graft biopsy, using algorithms to generate a report. #NephJc 🔗pubmed.ncbi.nlm.nih.gov/37310258/

T3a 📌So what was the conclusion?#NephJc 🔑Felzartamab demonstrated an acceptable safety and side-effect profile with potential therapeutic benefit in AMR occurring 180 days of transplantation